Success hinges on collaboration

Get in touch

Whether you're a visionary research team seeking support or an investor looking to make a meaningful impact, we're here to facilitate connections that drive the future of healthcare.

Send us a message

Why choose us

Why choose us

Biotech BD Engine

We don’t cold-call the industry, we tap a warm, TA-specific BD&L network built from years of doing deals. Senior operators who’ve sat on the sponsor side run targeting, meetings, and diligence, then craft option/licensing/co-dev terms that move from first intro to negotiated term sheets with pace and precision.

Biotech BD Engine

We don’t cold-call the industry, we tap a warm, TA-specific BD&L network built from years of doing deals. Senior operators who’ve sat on the sponsor side run targeting, meetings, and diligence, then craft option/licensing/co-dev terms that move from first intro to negotiated term sheets with pace and precision.

Biotech BD Engine

We don’t cold-call the industry, we tap a warm, TA-specific BD&L network built from years of doing deals. Senior operators who’ve sat on the sponsor side run targeting, meetings, and diligence, then craft option/licensing/co-dev terms that move from first intro to negotiated term sheets with pace and precision.

Regulatory to Approval

Advisors who have taken assets from IND/CTA through BLA/NDA/MAA align clinical endpoints, CMC, and label from day one. With precedent-driven FDA/EMA interactions and thoughtfully timed expedited pathways, we remove avoidable surprises that stall partner reviews.

Regulatory to Approval

Advisors who have taken assets from IND/CTA through BLA/NDA/MAA align clinical endpoints, CMC, and label from day one. With precedent-driven FDA/EMA interactions and thoughtfully timed expedited pathways, we remove avoidable surprises that stall partner reviews.

Regulatory to Approval

Advisors who have taken assets from IND/CTA through BLA/NDA/MAA align clinical endpoints, CMC, and label from day one. With precedent-driven FDA/EMA interactions and thoughtfully timed expedited pathways, we remove avoidable surprises that stall partner reviews.

Global, Focused Execution

Asia to US/EU without the noise. Senior leads stay on the field, from strategy to outreach to signatures, holding a tight cadence, clear metrics, and an unblinking focus on meetings, diligence, and signed term sheets.

Global, Focused Execution

Asia to US/EU without the noise. Senior leads stay on the field, from strategy to outreach to signatures, holding a tight cadence, clear metrics, and an unblinking focus on meetings, diligence, and signed term sheets.

Global, Focused Execution

Asia to US/EU without the noise. Senior leads stay on the field, from strategy to outreach to signatures, holding a tight cadence, clear metrics, and an unblinking focus on meetings, diligence, and signed term sheets.

Rely on us as your cross-border partner for BioPharma strategy, BD&L, and investor support. We help you refine your development and market strategy, identify and approach the right partners, and shape transaction structures that create long-term value for both innovators and investors.

Kristoffer Danielsson

Founder

Rely on us as your cross-border partner for BioPharma strategy, BD&L, and investor support. We help you refine your development and market strategy, identify and approach the right partners, and shape transaction structures that create long-term value for both innovators and investors.

Kristoffer Danielsson

Founder

Rely on us as your cross-border partner for BioPharma strategy, BD&L, and investor support. We help you refine your development and market strategy, identify and approach the right partners, and shape transaction structures that create long-term value for both innovators and investors.

Kristoffer Danielsson

Founder

We align BioPharma innovation, capital, and strategy cross borders.

We connect visionary researchers and impact-driven investors to shape the future of healthcare.

We align BioPharma innovation, capital, and strategy cross borders.

We connect visionary researchers and impact-driven investors to shape the future of healthcare.

We align BioPharma innovation, capital, and strategy cross borders.

We connect visionary researchers and impact-driven investors to shape the future of healthcare.

Logo

Deep domain expertise. Better BioPharma deals

Where Visionaries Shape The Future And Leave a Lasting Legacy

© Jarlen Capital powered by Sphere Corporate